TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
576,917
|
466,021
|
461,386 |
Financial expenses |
5,452
|
3,903
|
3,023 |
Earnings before taxes |
15,971
|
27,269
|
24,620 |
EBITDA |
42,243
|
47,601
|
38,859 |
Total assets |
517,388
|
444,413
|
450,332 |
Current assets |
264,115
|
192,262
|
177,036 |
Current liabilities |
183,255
|
91,935
|
75,756 |
Equity capital |
312,768
|
221,967
|
215,660 |
- share capital |
9,459
|
9,752
|
10,476 |
Employees (average) |
312
|
278
|
256 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
60.5%
|
49.9%
|
47.9% |
Turnover per employee |
1,849
|
1,676
|
1,802 |
Profit as a percentage of turnover |
2.8%
|
5.9%
|
5.3% |
Return on assets (ROA) |
4.1%
|
7.0%
|
6.1% |
Current ratio |
144.1%
|
209.1%
|
233.7% |
Return on equity (ROE) |
5.1%
|
12.3%
|
11.4% |
Change turnover |
124,902
|
36,512
|
96,824 |
Change turnover % |
28%
|
9%
|
27% |
Chg. No. of employees |
34
|
22
|
55 |
Chg. No. of employees % |
12%
|
9%
|
27% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.